TriLinc Global Impact Fund LLC
Company Information
Industry Finance Services
SIC Code 6199
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting company
State of Incorporation DE
Business Address 1230 Rosecrans Ave, Manhattan Beach, CA, 90266
Mailing Address 1230 Rosecrans Ave, Manhattan Beach, CA, 90266
Phone 310-997-0580
Fiscal Year End 1231
EIN 364732802
Financial Overview
FY2025
$12.47M
Net Income
$285.59M
Total Assets
$98K
Cash & Equivalents
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 10-K Annual financial report | March 30, 2026 | View on SEC |
| 8-K Current report of material events | March 26, 2026 | View on SEC |
| 8-K Current report of material events | February 25, 2026 | View on SEC |
| 8-K Current report of material events | January 23, 2026 | View on SEC |
| 8-K Current report of material events | December 19, 2025 | View on SEC |
| 8-K Current report of material events | November 26, 2025 | View on SEC |
| 10-Q Quarterly financial report | November 14, 2025 | View on SEC |
| 8-K Current report of material events | October 20, 2025 | View on SEC |
| 8-K Current report of material events | September 22, 2025 | View on SEC |
| 8-K Current report of material events | August 20, 2025 | View on SEC |
Annual Reports
10-K March 30, 2026
- Active recovery strategy focused on capital preservation and asset liquidation.
- Successful recovery of $10 million to $15 million in settlements over the last two years.
Related Companies
Companies in the same industry (SIC: 6199)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.